Owens J G, Kamerling S G, Stanton S R, Keowen M L
Department of Veterinary Physiology, Pharmacology and Toxicology, School of Veterinary Medicine, Louisiana State University, Baton Rouge 70803, USA.
Equine Vet J. 1995 Jul;27(4):296-300. doi: 10.1111/j.2042-3306.1995.tb03080.x.
The analgesic effects of the nonsteroidal anti-inflammatory drugs, ketoprofen (2.2 and 3.63 mg/kg bwt) and phenylbutazone (4.4 mg/kg bwt) were compared in 7 horses with chronic laminitis. Hoof pain was quantified objectively by means of an electronic hoof tester and lameness was subjectively graded on a modified Obel scale. Ketoprofen at a dose of 3.63 mg/kg bwt (phenylbutazone equimolar dose) reduced hoof pain and lameness to a greater extent than the 2.2 mg/kg dose and phenylbutazone. These effects were still present at 24 h in 3 of the 4 pain tests, including lameness grade. These data suggest that ketoprofen at the dosage rate of 1.65 times the recommended therapeutic dose was more potent than phenylbutazone in alleviating chronic pain and lameness in horses.
在7匹患有慢性蹄叶炎的马中,比较了非甾体抗炎药酮洛芬(2.2毫克/千克体重和3.63毫克/千克体重)和保泰松(4.4毫克/千克体重)的镇痛效果。通过电子蹄测试仪客观地量化蹄部疼痛,并根据改良的奥贝尔量表主观地对跛行进行分级。剂量为3.63毫克/千克体重(与保泰松等摩尔剂量)的酮洛芬比2.2毫克/千克剂量的酮洛芬和保泰松在更大程度上减轻了蹄部疼痛和跛行。在4项疼痛测试中的3项(包括跛行分级)中,这些效果在24小时时仍然存在。这些数据表明,剂量为推荐治疗剂量1.65倍的酮洛芬在减轻马的慢性疼痛和跛行方面比保泰松更有效。